Abstract
Purpose
Previous work has shown nitric oxide (NO) contributes to ~15% of the hyperemic response to dynamic exercise in healthy humans. This NO-mediated vasodilation occurs, in part, via increases in intracellular cyclic guanosine monophosphate (cGMP), which is catabolized by phosphodiesterase. We sought to examine the effect of phosphodiesterase-5 (PDE-5) inhibition on forearm blood flow (FBF) responses to dynamic handgrip exercise in healthy humans and the role of NO. We hypothesized exercise hyperemia would be augmented by sildenafil citrate (SDF, PDE-5 inhibitor). We further hypothesized any effect of SDF on exercise hyperemia would be abolished with intra-arterial infusion of the NO synthase (NOS) inhibitor L-NG-monomethyl arginine (L-NMMA).
Methods
FBF (Doppler ultrasound) was assessed at rest and during 5 min of dynamic forearm handgrip exercise at 15% of maximal voluntary contraction under control (saline) conditions and during 3 experimental protocols: (1) oral SDF (n = 10), (2) intra-arterial L-NMMA (n = 20), (3) SDF and L-NMMA (n = 10). FBF responses to intra-arterial sodium nitroprusside (NTP, NO donor) were also assessed.
Results
FBF increased with exercise (p < 0.01). Intra-arterial infusion of L-NMMA resulted in a reduction in exercise hyperemia (17 ± 1 to 15 ± 1 mL/dL/min, p < 0.01). Although the hyperemic response to NTP was augmented by SDF (area under the curve: 41 ± 7 vs 61 ± 11 AU, p < 0.01), there was no effect of SDF on exercise hyperemia (p = 0.33).
Conclusions
Despite improving NTP-mediated vasodilation, oral SDF failed to augment exercise hyperemia in young, healthy adults. These observations reflect a minor contribution of NO and the cGMP pathway during exercise hyperemia in healthy young humans.
Similar content being viewed by others
Abbreviations
- ACH:
-
Acetylcholine
- ANOVA:
-
Analysis of variance
- ATP:
-
Adenosine triphosphate
- AU:
-
Arbitrary units
- AUC:
-
Area under the curve
- BMI:
-
Body mass index
- cGMP:
-
Cyclic guanosine monophosphate
- eNOS:
-
Endothelial nitric oxide synthase
- FBF:
-
Forearm blood flow
- FVC:
-
Forearm vascular conductance
- L-NMMA:
-
L-NG-monomethyl arginine
- MSNA:
-
Muscle sympathetic nerve activity
- MVC:
-
Maximal voluntary contraction
- NO:
-
Nitric oxide
- NOS:
-
Nitric oxide synthase
- NTP:
-
Sodium nitroprusside
- PDE-5:
-
Phosphodiesterase-5
- SDF:
-
Sildenafil citrate
References
Attina TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ (2008) Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients. J Hypertens 26:501–507
Blaise S, Hellmann M, Roustit M, Isnard S, Cracowski JL (2010) Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers. Br J Pharmacol 160:1128–1134
Bradley SJ, Kingwell BA, McConell GK (1999) Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 48:1815–1821
Casey DP, Curry TB, Wilkins BW, Joyner MJ (2011) Nitric oxide-mediated vasodilation becomes independent of beta-adrenergic receptor activation with increased intensity of hypoxic exercise. J Appl Physiol 110:687–694
Casey DP, Treichler DP, Ganger CTT, Schneider AC, Ueda K (2015) Acute dietary nitrate supplementation enhances compensatory vasodilation during hypoxic exercise in older adults. J Appl Physiol 118:178–186
Dinenno FA, Joyner MJ (2003) Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol 553:281–292
Dinenno FA, Joyner MJ (2004) Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracting human skeletal muscle. Am J Physiol Heart Circ Physiol 287:22
Dishy V, Sofowora G, Harris PA, Kandcer M, Zhan F, Wood AJ, Stein CM (2001) The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin Pharmacol Ther 70:270–279
Dishy V, Harris PA, Pierce R, Prasad HC, Sofowora G, Bonar HL, Wood AJ, Stein CM (2004) Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers. Br J Clin Pharmacol 57:209–212
Dopp JM, Agapitov AV, Sinkey CA, Haynes WG, Phillips BG (2013) Sildenafil increases sympathetically mediated vascular tone in humans. Am J Hypertens 26:762–769
Duffy SJ, New G, Tran BT, Harper RW, Meredith IT (1999) Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 276:H663–H670
Dyke CK, Proctor DN, Dietz NM, Joyner MJ (1995) Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. J Physiol 488:259–265
Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S, Takeshita A (1994) Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation 90:2886–2890
Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, Musch TI, Poole DC (2013) Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats. J Physiol 591:547–557
Frandsenn U, Bangsbo J, Sander M, Hoffner L, Betak A, Saltin B, Hellsten Y (2001) Exercise-induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with N(G)-nitro-l-arginine methyl ester in humans. J Physiol 531:257–264
Ghofrani HA, Osterloh IH, Grimminger F (2006) Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 5:689–702
Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA (1994) Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 90:2853–2858
Gordon MB, Jain R, Beckman JA, Creager MA (2002) The contribution of nitric oxide to exercise hyperemia in the human forearm. Vasc Med 7:163–168
Green DJ, Bilsborough W, Naylor LH, Reed C, Wright J, O’Driscoll G, Walsh JH (2005) Comparison of forearm blood flow responses to incremental handgrip and cycle ergometer exercise: relative contribution of nitric oxide. J Physiol 562:617–628
Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA (2002) The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 40:1232–1240
Harrell JW, Johansson RE, Evans TD, Sebranek JJ, Walker BJ, Eldridge MW, Serlin RC, Schrage WG (2015) Preserved microvascular endothelial function in young, obese adults with functional loss of nitric oxide signaling. Front Physiol 6:387. doi:10.3389/fphys.2015.00387
Heinonen I, Saltin B, Kemppainen J, Sipila HT, Oikonen V, Nuutila P, Knuuti J, Kalliokoski K, Hellsten Y (2011) Skeletal muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet study with nitric oxide and cyclooxygenase inhibition. Am J Physiol Heart Circ Physiol 300:21
Herr MD, Hogeman CS, Koch DW, Krishnan A, Momen A, Leuenberger UA (2010) A real-time device for converting Doppler ultrasound audio signals into fluid flow velocity. Am J Physiol Heart Circ Physiol 298:19
Hryniewicz K, Dimayuga C, Hudaihed A, Androne AS, Zheng H, Jankowski K, Katz SD (2005) Inhibition of angiotensin-converting enzyme and phosphodiesterase type 5 improves endothelial function in heart failure. Clin Sci 108:331–338
Hsu AR, Barnholt KE, Grundmann NK, Lin JH, McCallum SW, Friedlander AL (2006) Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. J Appl Physiol 100:2031–2040
Jackson G, Benjamin N, Jackson N, Allen MJ (1999) Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 83:13C–20C
Joyner MJ, Casey DP (2015) Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs. Physiol Rev 95:549–601
Joyner MJ, Dietz NM (1997) Nitric oxide and vasodilation in human limbs. J Appl Physiol 83:1785–1796
Katz SD, Krum H, Khan T, Knecht M (1996) Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 28:585–590
Kellawan JM, Johansson RE, Harrell JW, Sebranek JJ, Walker BJ, Eldridge MW, Schrage WG (2015) Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase. Eur J Appl Physiol 115:1735–1746
Kimura M, Higashi Y, Hara K, Noma K, Sasaki S, Nakagawa K, Goto C, Oshima T, Yoshizumi M, Chayama K (2003) PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers. Hypertension 41:1106–1110
Lee JS, Stebbins CL, Jung E, Nho H, Kim JK, Chang MJ, Choi HM (2015) Effects of chronic dietary nitrate supplementation on the hemodynamic response to dynamic exercise. Am J Physiol Regul Integr Comp Physiol 309:R459–R466
Maiorana A, O’Driscoll G, Taylor R, Green D (2003) Exercise and the nitric oxide vasodilator system. Sports Med 33:1013–1035
Martin EA, Nicholson WT, Eisenach JH, Charkoudian N, Joyner MJ (2006) Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia. J Appl Physiol 101:492–499
Maxwell AJ, Schauble E, Bernstein D, Cooke JP (1998) Limb blood flow during exercise is dependent on nitric oxide. Circulation 98:369–374
Mayer BX, Mensik C, Krishnaswami S, Derendorf H, Eichler HG, Schmetterer L, Wolzt M (1999) Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans. Br J Clin Pharmacol 47:539–544
Moreland RB, Goldstein I, Traish A (1998) Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci 62:309–318
Nichols DJ, Muirhead GJ, Harness JA (2002) Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol 53(Suppl 1):5S–12S
Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, Somers VK (2000) Sympathetic activation by sildenafil. Circulation 102:3068–3073
Radegran G, Saltin B (1999) Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol 276:H1951–H1960
Robinson SD, Ludlam CA, Boon NA, Newby DE (2006) Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease. Heart 92:170–176
Saltin B, Radegran G, Koskolou MD, Roach RC (1998) Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand 162:421–436
Schalcher C, Schad K, Brunner-La Rocca HP, Schindler R, Oechslin E, Scharf C, Suetsch G, Bertel O, Kiowski W (2002) Interaction of sildenafil with cAMP-mediated vasodilation in vivo. Hypertension 40:763–767
Schofield RS, Edwards DG, Schuler BT, Estrada J, Aranda JM, Pauly DF, Hill JA, Aggarwal R, Nichols WW (2003) Vascular effects of sildenafil in hypertensive cardiac transplant recipients. Am J Hypertens 16:874–877
Schrage WG, Joyner MJ, Dinenno FA (2004) Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans. J Physiol 557:599–611
Shepherd J (1983) Circulation to skeletal muscle. In: Abboud JSAF (ed) Handbook of physiology: the cardiovascular system peripheral circulation and blood flow. American Physiological Society, Bethesda, pp 319–370
Shepherd JR, Joyner MJ, Dinenno FA, Curry TB, Ranadive SM (2016) Prolonged adenosine triphosphate infusion and exercise hyperemia in humans. J Appl Physiol 121:629–635
Shoemaker JK, Halliwill JR, Hughson RL, Joyner MJ (1997) Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol 273:H2388–H2395
Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R (2006) A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 151:e1–e5
Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z, Joyner MJ (2002) Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541:623–635
Vlachopoulos C, Tsekoura D, Alexopoulos N, Panagiotakos D, Aznaouridis K, Stefanadis C (2004) Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction. Am J Hypertens 17:1040–1044
Wilkins BW, Pike TL, Martin EA, Curry TB, Ceridon ML, Joyner MJ (2008) Exercise intensity-dependent contribution of beta-adrenergic receptor-mediated vasodilatation in hypoxic humans. J Physiol 586:1195–1205
Wilson JR, Kapoor S (1993) Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J Appl Physiol 75:2740–2744
Acknowledgements
Many thanks to our research participants. Technical and other support was provided by Madhuri Somaraju, Christopher Johnson, Karen Krucker, Brandon Madery, Shelly Roberts, Branton Walker, and Brian Welch (Mayo Clinic), and Meghan Crain, Josh Sebranek, Marlowe Eldridge, Brad Walker, John Harrell, Rebecca Johansson, and Garrett Peltonen (University of Wisconsin).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.
Funding
Financial support was provided by the National Institutes of Health (NIH) HL46493 (MJJ), HL078019 (MJJ), HL105820 (WGS), RR17520 (TBC), UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), as well as the Mayo Clinic Department of Anesthesiology.
Conflict of interest
The authors declare no relevant conflicts of interest.
Additional information
Communicated by David C. Poole.
Rights and permissions
About this article
Cite this article
Limberg, J.K., Malterer, K.R., Mikhail Kellawan, J. et al. Potentiation of the NO-cGMP pathway and blood flow responses during dynamic exercise in healthy humans. Eur J Appl Physiol 117, 237–246 (2017). https://doi.org/10.1007/s00421-016-3523-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-016-3523-7